Acupuncture for Body Weight Control

March 14, 2017 updated by: ZhaoXiang Bian, Hong Kong Baptist University

Acupuncture for Body Weight Control: A Pilot Randomized Controlled Trial

In this study, a 18-week, single-blinded, randomized controlled clinical trial will be conducted to evaluate the effectiveness, efficacy and safety of acupuncture on weight control in Hong Kong.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This is a pilot single-blind, randomized, sham-controlled trial. 72 participants will be randomly assigned to acupuncture group or control group. The duration of the treatment will be 8 weeks with 2 sessions per week and the follow-up period will be 8 weeks.

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • aged between 18 and 65 years old;
  • body mass index (BMI)≥25 kg/m2;
  • having not received any other weight control measures or any medical and/or drug history within the last 3 months.

Exclusion Criteria:

  • endocrine diseases;
  • heart diseases;
  • patients with pacemaker;
  • allergy and immunology diseases;
  • having bleeding tendency;
  • pregnant or lactating women;
  • having impaired hepatic or renal function;
  • stroke or otherwise unable to exercise.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acupuncture group

Eight body acupuncture points will be chosen as Tianshu(ST-25), Daheng(SP-15), Daimai(GB-26), Qihai(CV-6), Zhongwan(CV-12), Zusanli(ST-36), Fenlong(ST-40), Sanyinjiao(SP-6). The needles will be retained for 30 minutes.

Participants of the treatment group will additionally receive unilateral auricular acupressure at four auricular points as Hunger, Shen men, Spleen and Stomach with Semen Vaccariae embedded within adhesive tape in each treatment session. Acupressure will be applied by the subjects with repeat pressing of the tape with fingertips for 3 minutes per point, 3 times per day. The embedded tape will be retained in-situ until the next visit and then the alternate side of ear will be treated.

Eight body acupuncture points will be chosen as Tianshu(ST-25), Daheng(SP-15), Daimai(GB-26), Qihai(CV-6), Zhongwan(CV-12), Zusanli(ST-36), Fenlong(ST-40), Sanyinjiao(SP-6). The needles will be retained for 30 minutes.

Participants of the treatment group will additionally receive unilateral auricular acupressure at four auricular points as Hunger, Shen men, Spleen and Stomach with Semen Vaccariae embedded within adhesive tape in each treatment session. Acupressure will be applied by the subjects with repeat pressing of the tape with fingertips for 3 minutes per point, 3 times per day. The embedded tape will be retained in-situ until the next visit and then the alternate side of ear will be treated.

Sham Comparator: Control group

For subjects assigned to control group, Streitberger's non-invasive acupuncture needles (Gauge 8 x 1.2" / 0.30 x 30 mm) will be applied to serve as sham control at the same acupoints with the same stimulation modality, except that the needles are only adhered to the skin instead of insertion.

The Semen Vaccariae embedded tape used in treatment group will be applied on 4 non-acupoints at the helix unilaterally, retained until the next visit and then the alternate ear will be used.

Eight body acupuncture points will be chosen as Tianshu(ST-25), Daheng(SP-15), Daimai(GB-26), Qihai(CV-6), Zhongwan(CV-12), Zusanli(ST-36), Fenlong(ST-40), Sanyinjiao(SP-6). The needles will be retained for 30 minutes.

Participants of the treatment group will additionally receive unilateral auricular acupressure at four auricular points as Hunger, Shen men, Spleen and Stomach with Semen Vaccariae embedded within adhesive tape in each treatment session. Acupressure will be applied by the subjects with repeat pressing of the tape with fingertips for 3 minutes per point, 3 times per day. The embedded tape will be retained in-situ until the next visit and then the alternate side of ear will be treated.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in body weight during treatment and follow up
Time Frame: The change in body weight will be assessed every two weeks during 8-week treatment and 8-week follow up
measured by Omron KARADA Scan Body Composition & Scale
The change in body weight will be assessed every two weeks during 8-week treatment and 8-week follow up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Body Mass Index (BMI) during treatment and follow up
Time Frame: The change in BMI will be assessed every two weeks during 8-week treatment and 8-week follow up
The change in Body Mass Index (BMI) will be measured by Omron KARADA Scan Body Composition & Scale
The change in BMI will be assessed every two weeks during 8-week treatment and 8-week follow up
Change in waist circumference during treatment and follow up
Time Frame: The change in waist circumference will be assessed every two weeks during 8-week treatment and 8-week follow up
The change in waist circumference will be assessed every two weeks during 8-week treatment and 8-week follow up
Change in hip circumference
Time Frame: The change in hip circumference will be assessed every two weeks during 8-week treatment and 8-week follow up
The change in hip circumference will be assessed every two weeks during 8-week treatment and 8-week follow up
Change in body fat percentage during treatment and follow up
Time Frame: The change in body fat percentage will be assessed every two weeks during 8-week treatment and 8-week follow up
The change in body fat percentage will be measured by Omron KARADA Scan Body Composition & Scale
The change in body fat percentage will be assessed every two weeks during 8-week treatment and 8-week follow up
Number of patients with adverse events after treatment
Time Frame: Number of patients with adverse events after treatment will be recorded and compared among the two groups during 8-week treatment and 8-week follow up
Number of patients with adverse events after treatment will be recorded and compared among the two groups during 8-week treatment and 8-week follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Zhaoxiang Bian, MD., Ph.D, Hong Kong Baptist University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2015

Primary Completion (Actual)

October 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

July 30, 2015

First Submitted That Met QC Criteria

August 5, 2015

First Posted (Estimate)

August 6, 2015

Study Record Updates

Last Update Posted (Actual)

March 15, 2017

Last Update Submitted That Met QC Criteria

March 14, 2017

Last Verified

March 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AcupBWC001

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Acupuncture

3
Subscribe